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Abstract
The commercialization of university-based research occurs to varying degrees
between academic institutions. Previous studies have found that multiple
barriers can impede the effectiveness and efficiency by which academic
research is commercialized. This case study was designed to better
understand the impediments to research commercialization at the University of
Kentucky via a survey and interview with three successful academic
entrepreneurs. The study also garnered insight from the individuals as to how
the commercialization process could be improved. Issues with
commercialization infrastructure; a lack of emphasis, at the university level, on
the importance of research commercialization; a void in an entrepreneurial
culture on campus; inhibitory commercialization policies; and a lack of business
and commercialization knowledge among faculty were highlighted as the most
significant barriers. The research subjects also suggested that
commercialization activity may generally increase if a number of factors were
mitigated. Such insight can be communicated to the administrative leadership
of the commercialization process at the University of Kentucky. Long term,
improving university-based research commercialization will allow academic
researchers to be more active and successful entrepreneurs such that
intellectual property will progress more freely to the marketplace for the benefit
of inventors, universities and society.
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REVISED

Amendments from Version 1

In response to the reviewers’ comments, we have made several
changes of which the most substantial are that we have clarified
the overall intent of the study, increased the sample size and we
have added a description of the study’s limitations. We have also
responded to each reviewers’ report below.
See referee reports

Introduction
Research is a vital component of the mission of universities, and
indeed academic institutions conduct a substantial volume of
research that is funded by government, industry and philanthropic
agencies. Development or the commercialization of research should
also be a key component of the research mission such that novel
ideas, techniques and products can enter the marketplace for the
benefit of a variety of stakeholders including inventors, universities
and society. In order to facilitate academic-based commercialization, legislation, such as the Bayh-Dole Act, provides universities
the legal framework for commercializing the research that is developed within university settings1,2.
In a commercialization survey conducted by the Association of
University Technology Managers (AUTM), in 2013, United Statesbased institutions generated over 24,000 disclosures, obtained
over 5,000 new patents, executed over 5,000 licensing agreements,
formed over 800 start-up companies and generated $2.75 billion in
license income3. Despite this overall success, academic researchers experience many issues that obstruct the commercialization

of research within higher education settings. Previous studies at
academic institutions have documented challenges to the commercialization process that include, but are not limited to: risk aversion; constraints on faculty time; lack of financial support; policy/
regulation barriers; infrastructure insufficiencies; lack of a common
understanding of the value of research commercialization; lack of
entrepreneurial thinking among faculty; and lack of interaction
and collaboration between universities and industry4–10. A previous
study at the University of Kentucky found that expense, time constraints, insufficient infrastructure and lack of industry partnerships
were the most common factors experienced by cancer researchers
that impede research commercialization11. Ultimately, challenges to
the effective and efficient commercialization of research inhibits
obtaining the maximum benefit of university research in that such
barriers can prevent university-based innovation from progressing to the marketplace for the benefit of inventors, universities and
society.
The University of Kentucky commercializes its research through the
Intellectual Property Development and Technology Transfer Office,
a unit of the Office of the Vice President for Research. Through
this office, the university’s research commercialization activities
are historically modest compared to its benchmark institutions. The
university currently ranks last among its benchmark institutions
in regard to several commercialization metrics including in staffing, invention disclosures, patent applications and license/options
executed (Table 1). And, growth in commercialization activity has
been relatively flat from 2010–2013 with the exception of a recent
increase in license income (Table 2). These data could suggest that
the University of Kentucky may experience additional commercialization barriers as compared to its benchmark institutions and/or a
higher magnitude of common barriers among institutions.

Table 1. University of Kentucky research commercialization metrics versus select benchmark institutions (2013)*.

Patent
Applications

Patents
Issued

Licenses
and
Options
Executed

122

49

46

384

155

62

Research
Expenditures

Licensing
FTE

Invention
Disclosures

Michigan State University

$515,707,000

5.50

Ohio State University

$967,306,055

9.00

Name of Institution

Start-ups

License
Income
Received

33

1

$3,302,322

50

10

$2,105,127

University of Arizona

$629,466,000

8.50

144

76

27

48

3

$926,023

University of Florida

$544,936,847

13.50

335

152

107

140

16

$28,067,988

University of Iowa

$435,377,000

6.00

96

53

24

29

6

$1,205,342

University of Kentucky

$239,715,000

2.00

58

17

30

9

3

$4,800,000

University of Michigan

$1,328,721,165

9.00

412

148

128

108

9

$14,464,565

University of Minnesota

$882,022,000

18.00

331

148

64

91

14

$38,030,470

University of North
Carolina, Chapel Hill

$777,976,677

6.00

138

72

25

56

14

$3,783,545

$1,123,501,000

18.00

386

167

157

63

7

$94,170,000

University of WisconsinMadison

*Data obtained from the fiscal year 2013 AUTM report.
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Table 2. University of Kentucky research commercialization activity,
2010–2013*.
Commercialization
Activity

2010

2011

2012

2013

Disclosures

57

59

83

58

Patent Applications

28

22

12

17

Patents Issued

28

26

29

30

Licenses/Options
Executed

9

8

9

9

Start-ups
License Income

6

7

6

3

$2,161,743

$1,544,664

$1,628,264

$4,800,000

*Data obtained from the fiscal year 2010–2013 AUTM reports.

The study herein was designed as a supplement to the previous
study at the University of Kentucky11 and focused on obtaining a
more detailed understanding of the impediments to commercializing research at the university from the perspective of three faculty
members that have been successful in the continuum of commercialization through successfully obtaining patents, licensing intellectual property and forming start-up companies. The rationale for
conducting this supplemental study with only successful academic
entrepreneurs was that we believed that more focused and individualized conversations with such entrepreneurs could provide more
insight into the commercialization process versus conducting the
study with individuals that have had more limited or no experience
in commercializing research.

Methods
The study herein is a supplement to and modeled closely after a
similar, larger scale study conducted at the University of Kentucky
specifically among cancer researchers11. The methodology and
design of the study was qualitative in nature and was based on two
modules: an online survey (included as Supplementary materials S1)
followed by a face-to-face interview. It is important to note that
the prior study11 did not include a face-to-face interview and was
conducted with faculty that had both successfully commercialized
their research and those that had not. It is also noteworthy that the
respondents for this supplemental work span different research
categories as defined in Table 4. The purpose of this supplemental
research was to obtain more detailed information, primarily through
the face-to-face interview, on the impediments to the commercialization of research at the University of Kentucky.
The selection criteria for inclusion in the study was that the selected
participants must be faculty members, have active research programs and be successful academic entrepreneurs based on having
obtained patents, licensed intellectual property and created start-up
companies. The research subjects for this study were identified
through searches of publically available databases containing information on the selection criteria. For module one, data were collected and managed using the Research Electronic Data Capture
(REDCap) tool. REDCap is a secure, Internet-based study-support

application12. Module two data were recorded in written format during the face-to-face interview.
There are several limitations associated with this study. As a limited
case study designed as a supplement to prior research11, the results
may not be translatable to other situations or research questions
beyond that addressed in the original study11, and the opinions of
the three respondents may not be representative of all the stakeholders involved in the commercialization landscape at the University of
Kentucky or elsewhere. Thus, the findings may not be generalizable
to all faculty either at the University of Kentucky or at other universities, and the findings may or may not be capable of being generalized to other research areas. Further, as a cross-sectional study, the
barriers experienced by the participants outside of the data collection window may not have been captured. Subject selection bias,
which could lead to data and outcome bias, may also exist. Lastly,
the study was designed to identify general challenges, thus more
specific challenges were likely not captured by this analysis. Despite
these limitations, the data obtained from this study, especially from
the face-to-face interviews, provide additional supplemental information that enhances the findings of the previous study11. Thus, this
supplemental work provides more detailed information that can be
presented to the administrative leadership of the commercialization
process at the University of Kentucky.
This study was determined to not require review by the University of Kentucky Institutional Review Board. The research subjects
consented to participate in the study electronically via engagement
with the online survey and chose to participate in both modules
of the study. The participants chose to remain anonymous beyond
interaction with the investigators involved in the study.

Results
Professional productivity and commercialization
perspective
The first series of survey questions, summarized in Table 3, aimed to
assess the subjects’ category of research, professional productivity
and their perspective on research commercialization. Respondent 1
classified his research as “translational;” he feels satisfied with his
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Table 3. Professional productivity and commercialization perspective.
Question

Respondent 1

Respondent 2

Respondent 3

Translational

Basic

Basic/Translational

Do you feel that your research results are sufficiently utilized
through the generation of publications, grants, and other forms of
professional productivity?

Yes

No

Yes

Do you intend to commercialize your research in the future?

Yes

Yes

No

Do you think research commercialization is important to promote
within an academic setting?

Yes

Yes

Yes

Do you think the University of Kentucky places an emphasis on
academic research commercialization to faculty?

No

No

No

Do you think your research field places an emphasis on academic
research commercialization?

Yes

No

Yes

Which category best describes your research?

Table 4. Impediments to research commercialization.
Potential Barrier

Respondent 1

Respondent 2

Respondent 3

There are no barriers to commercializing research at the
University of Kentucky

No

No

No

There is unwanted risk associated with commercialization

Yes

No

Yes

I lack the expendable time

No

No

Yes

There is excessive expense

No

No

Yes

There is a lack of investors

Yes

No

Yes

There is a lack of infrastructure including facilities and staff to
help in the commercialization process

Yes

Yes

Yes

Unsupportive University policies, procedures and/or regulations

Yes

No

Yes

Unsupportive federal policies, procedures and/or regulations

Yes

No

No

There is a lack of industry partners

No

No

Yes

Limited or no commercial application of my research exists

No

No

No

There is a lack of importance to academia

No

Yes

No

There is a lack of importance to my field

No

No

No

There is a lack of benefit to society

No

No

No

I have no interest in commercialization

No

No

No

Other barriers not listed

Yes

Yes

No

level of professional productivity in terms of publishing research
manuscripts, obtaining grant funding and other means of academic
productivity; and he indicated that he intends to commercialize
additional research in the future. Despite believing that research
commercialization is important in the academic setting and that
his research field values such work, he feels that the University of
Kentucky places little emphasis on and thus does not greatly value
research commercialization. Respondent 2 classified his research as
“basic;” he feels that his research is underutilized; and he intends
to continue commercializing his work. Further, respondent 2
believes commercialization is important in an academic setting,
yet the University of Kentucky does not emphasize such activity
and he believes that his research field does not place an emphasis on commercialization. Respondent 3 classified her research as

“basic/translational;” she is satisfied with her level of professional
productivity; and, interestingly, despite having developed intellectual property and starting a company, she indicated that she
may not pursue the commercialization of her research again in the
future. Similar to respondent 1, respondent 3 also feels that research
commercialization is important in the academic setting and that
her research field values such activity, but that the University of
Kentucky does not value research commercialization.

Impediments to research commercialization
The second set of survey questions, summarized in Table 4,
addressed the research subjects’ perceived impediments to commercializing research. Respondent 1 believes that risk, lack of investors, commercialization infrastructure, unsupportive university and
Page 5 of 18
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federal policies, and “other barriers not listed” prohibit his efforts
to effectively and efficiently commercialize research. Respondent
2 feels that commercialization infrastructure, lack of importance
to academia (i.e., lack of emphasis placed on commercialization
by academia), and “other barriers not listed” are the impediments
that inhibit his commercialization efforts. The barriers identified by
respondent 3 include the presence of risk, lack of time, expense,
lack of investors, insufficient infrastructure, unsupportive university policies, and lack of industry partners.
In the face-to-face interview, respondent 1 indicated that the “other
barriers” included major prohibiting factors such as the lack of
university support/infrastructure in areas of market analysis, grant
development, and navigating legal matters including conflict of
interest and intellectual property ownership issues. Of these “other”
items, we had anticipated that such factors could be captured under
the commercialization infrastructure and/or policy categories of
answer choices in the survey. Ultimately, respondent 1 indicated
that infrastructure issues are the most significant factors that impede
research commercialization at the University of Kentucky. The subject also discussed how some of these barriers are more challenging
and more difficult to overcome and that he felt that the barriers he
has encountered are different at other universities. Respondent 2
indicated three major factors that negatively impact commercialization at the university and those are: 1) a lack of an entrepreneurial
culture at the university level which has eroded the interest faculty
have in pursuing the commercialization of their work; 2) inhibitory
commercialization policies and an unwillingness for those policies
to be malleable to individual commercialization situations/circumstances; and 3) insufficient and inhibitory commercialization infrastructure. Respondent 3 described the biggest barriers to academic
research commercialization as faculty’s lack of business knowledge
and commercialization background. Interestingly, she considers it
more the responsibility of each faculty member to drive any potential commercial aspect of their work rather than rely on resources
and support that may or may not exist at the university level. Since
the majority of faculty do not receive any training in business or

commercialization areas, she feels that this hampers the overall
commercialization activity on university campuses.
Similar to the previous study among cancer researchers11, these data
suggest that faculty members experience multiple barriers in the
commercialization process at the University of Kentucky. Additionally, in comparison with previous studies4–11, the data may suggest
that not all barriers are consistent or common between individual
faculty members (for example, expense, time constraints, insufficient infrastructure, and lack of industry partnerships were the most
common barriers experienced among University of Kentucky cancer researchers11). And, some barriers appear to be more prohibitive
than others.

Factors that could enhance research commercialization
The final set of questions, summarized in Table 5, were meant
to determine which impediments would need to be overcome in
order to increase faculty participation in research commercialization. Respondent 1 indicated that the barriers in the commercialization process do not deter him from attempting to commercialize
his research, however, he believes that reducing/mitigating all
the potential barriers surveyed, other than addressing royalty pay
to inventors, would enhance research commercialization activity
at the University of Kentucky. The subject also indicated that he
would utilize outside (off campus) commercialization resources to
lower the barriers he faces in order to improve his commercialization efforts. Respondent 2 would also use off campus resources to
enhance his commercialization efforts and he believes that providing faculty protected time for commercialization efforts, providing
additional and more helpful information to faculty about how to
commercialize research, increasing the financial support available to entrepreneurial faculty, enhancing the commercialization
infrastructure on campus, and increasing the emphasis placed on
research commercialization would improve the commercialization
activity at the university. Similar to respondents 1 and 2, respondent
3 would use off campus resources to commercialize her research,
and she feels that providing information on how to commercialize,

Table 5. Factors that could enhance research commercialization.
Factor

Respondent 1

Respondent 2

Respondent 3

Offering protected time specifically for commercialization activities

Yes

Yes

No

Increasing information on how to commercialize

Yes

Yes

Yes

Increasing financial support

Yes

Yes

Yes

Better and/or more infrastructure including facilities and staff to
help in the commercialization process

Yes

Yes

Yes

Revising university policies, procedures and/or regulations

Yes

No

Yes

Revising federal policies, procedures and/or regulations

Yes

No

No

Increasing links to industry

Yes

No

Yes

Increasing emphasis placed by academia and/or my research
field on the importance of research commercialization

Yes

Yes

No

Greater personal benefits including more royalty pay

No

No

No

Greater societal benefits

Yes

No

No

Nothing would help

No

No

No
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providing financial support, improving commercialization infrastructure, revising university policies, and increasing links to industry would improve commercialization activity at the University of
Kentucky.
These data are similar to the feelings reported by cancer researchers11
in which respondents believe that mitigating many factors would
presumably increase commercialization activity. Not all respondents, however, completely agree on all the factors that are important
to address.

Conclusion
This case study investigated the mindset of three successful academic entrepreneurs at the University of Kentucky in relation to
the status of the research commercialization process and in context
with the university’s general commercialization activity. The general state of the institution’s commercialization activity is modest
relative to its benchmark institutions and stagnant in growth over
time. The research subjects identified several factors that generally
impede research commercialization and the subjects agreed that
mitigating many factors may increase commercialization activity.
Infrastructure insufficiencies, a lack of an emphasis by the university on the importance of research commercialization, a low to nonexistent entrepreneurial culture on campus, inhibitory policies, and
a lack of business and commercialization knowledge among faculty
were highlighted as the most significant barriers. While generally
fitting with the impediments found at other universities and among
cancer researchers at the University of Kentucky4–11, the results suggest that not all barriers are common or consistent between faculty
and that some impediments may be more prohibitive than others.
It is likely that the barriers vary between and among disciplines
and the barriers may further vary based on an individual’s general
experience with the commercialization process.

These data can be shared with the University of Kentucky’s Intellectual Property Development and Technology Transfer Office and
the Office of the Vice President for Research and used as a guide
to make changes that will improve the research commercialization
process. The research subjects’ comments regarding commercialization infrastructure, a stagnant entrepreneurial culture, inhibitory commercialization policies, and faculty’s lack of business/
commercialization knowledge may be particularly important to
address in order to enhance commercialization activity at the
university. Additionally, similar work could be conducted at and
among other institutions. For example, a survey similar to the one
herein and that used in the prior study11 could be incorporated into
the yearly AUTM licensing survey in order to gauge, on a much
broader scale, the impediments to academic research commercialization as well as to understand how other institutions are mitigating
such impediments. Understanding how institutions that are highly
successful in commercializing research mitigate barriers in the
process would be greatly beneficial to institutions that have low to
modest commercialization activity.
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Scott Crick
Licensing Associate, Office of Technology Management, Washington University, St Louis, MO, USA
Overall, this version is definitely an improvement over V1. The major weakness I see remaining is the lack
of specific suggestions for improving the technology transfer process. The most ubiquitous complaints
seemed to be regarding the infrastructure, and the lack of appreciation of the importance and support for
commercialization. First, it would be nice to define what is meant by the infrastructure. This term is fairly
vague and could reasonably be viewed as fairly all-encompassing. A narrowing definition would be useful.
For example, is the infrastructure referring specifically to the Tech Transfer Office, which would suggest
the office is perhaps understaffed? Without more clearly defining the complaint, positing possible
mitigating improvements becomes more difficult. In short, I am going to recommend approval of the
article, but I think it would be improved by including specific suggestions for overcoming perceived
barriers to tech transfer.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
Competing Interests: No competing interests were disclosed.
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I would like to thank the authors for their specific responses to my initial comments and for clarifying many
of these concerns with substantial changes to the text of the submission that both clarify the purpose of
the study and add to the data collected.
My initial review focused on three main areas for consideration by the authors:
1. Conclusions based on the survey/interview of a single academic entrepreneur;
2. Expansion of perspectives on reasons for innovations not being commercialized and;

3. Increase engagement with academic entrepreneurs on campus that have been both successful
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3. Increase engagement with academic entrepreneurs on campus that have been both successful
and unsuccessful with bringing their ideas to market.
With the new submission, I believe the authors have addressed my three suggested areas of focus. It is
now much clearer to me that this work was a supplement to an initial study performed to understand
commercialization on campus. Through edits to the manuscript this rationale/purpose is now understood
as a follow-up rather than a total brand new analysis. As such, there was a certain methodology that was
being continued from the initial work that clarified the “customers” they were focused on as being faculty
members that have successfully commercialized research. The study also increased the number of
individuals that were interviewed from a single individual to multiple on campus allowing for a broader set
of perspectives than initially obtained. Further, the authors did add focus on the limitations with the study
based on design and purpose allowing the reader to more clearly understand the approach.
In conclusion, I would approve publication of this new version of the manuscript. The only additional
recommendation I would provide from a practical perspective is that when presenting these findings to the
university administrators, the authors should also offer some solutions to the issues they have uncovered.
Problem solving will be viewed more favorably than purely problem identifying.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
Competing Interests: No competing interests were disclosed.
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The goal of the authors was to document any impediments to the commercialization process at the
University of Kentucky. The study was spurred by the findings that UK significantly underperforms when
compared to peer institutions of similar size. A previous study was published in 2013 regarding this same
topic at UK for the commercialization of cancer research. In this study, similar surveys were conducted
with 3 entrepreneurial respondents as opposed to a larger cohort of cancer researchers in the previous
UK study.
The updated information from 2 more respondents is appreciated, but ideally it would be nice to have a
larger group than 3. Getting information from those that had a positive and a negative experience is
helpful to make changes to the system. If the ultimate goal is to provide this feedback to the UK TTO in
order to institute changes, more details would be helpful. Some aspects that I think would benefit from
further detail are the following:
1. Interviews of the actual TTO employees? What is keeping the University from making any
changes?
2. Some background information on what other universities have done to rebrand their TTO. There
have been many stories regarding offices doing an overhaul and rebranding and trying new things.
Table 5 is a good start in figuring out some areas that need more improvement. A section that
details what other offices have tried would be useful to people in technology transfer. The
suggestions listed in table 5 are fairly standard practices that TTOs must consider. Can you include
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suggestions listed in table 5 are fairly standard practices that TTOs must consider. Can you include
suggestions of how other universities have for instance increased links to industry or how they
have offered more information to researchers teaching them how to commercialize? What are the
policies or regulations that are restrictive at UK? Would utilizing more interns/students/post docs as
staff help in bringing in more disclosures or provide more hands to evaluate inventions?
Overall the authors claim that the goal is to present this data as a guide to the UK TTO to make changes.
It would be helpful to provide suggestions rather than telling them these results which they likely already
know and realize are a problem. It will be more useful to also provide some options that have been tried
by other universities rather than just pointing out the failures. With these additions I think the article would
be much stronger and more useful to other TTO offices.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
Competing Interests: No competing interests were disclosed.

Version 1
Referee Report 01 July 2015

doi:10.5256/f1000research.6961.r9270
Evan Facher
Enterprise Development, University of Pittsburgh, Pittsburgh, PA, USA
The study by Vanderford and Marcinkowski attempts to identify challenges to the commercialization of
innovations discovered at their institute of higher learning, the University of Kentucky. The goal of this
work is to improve the sluggish local climate for translation of discoveries by communicating the findings
resulting from this effort back to administrative leadership with the hope that the identification of these
impediments leads to real change. By deploying a survey and subsequent interviews the authors plan to
generate learnings sufficient to form the basis of their recommendations.
Movement of research discoveries from academic institutes to the marketplace is important not only for
these discoveries to have their societal impact but also to drive economic growth of a region. The
juxtaposition of most new jobs created over the last two decades coming from startup companies and
much innovation from academia serving as the impetus for these new entities hints at the regional
criticality of a university being able to successfully translate its discoveries into products reaching the
market.
While the Vanderford and Marcinkowski article has a solid thesis and very good intent, it is however
limited (in this reviewers mind) by a handful of items. First, the conclusions the authors generate are
based on the survey and interview of a single academic entrepreneur. The data achieved from this
individual is certainly very valuable but it might not be reflective of the other individuals on campus that
have had experiences with commercialization of university-based research. The challenges described by
this individual on campus ring true of the commercialization issues found throughout other academic
organizations; however due to the small sample size it is hard to draw solid conclusions for the University
of Kentucky as a whole. As one of the aims of the study is to report findings back to the administration
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organizations; however due to the small sample size it is hard to draw solid conclusions for the University
of Kentucky as a whole. As one of the aims of the study is to report findings back to the administration
with the goal of impacting change, I would suggest that the senior leadership, while sympathetic to the
challenges expressed by the authors, will not institute changes based on such a small set of data that
may not accurately reflect the general experiences of its academic entrepreneurs in totality.
I would recommend that the authors attempt to increase the number of study subjects to enhance the
power of their research. In addition to surveys/interviews with academics that have successfully
commercialized their innovations on campus, I would strongly urge the authors to include a set of
individuals that have had unsuccessful experiences as well. Learnings from this cohort might provide an
additional set of data to further drive the goals of enhancing translation at their institute.
The second item I would suggest the authors to contemplate in their assessments is expanding their
perspectives on reasons for an innovation not being commercialized. It seems as if the main focus of the
surveys/interviews is on structural elements involved in the workflow for moving a university idea to
commercialization. It is often that the main reason for the lack of translation has nothing to do with the
internal processes for moving the opportunity forward but rather that the innovation never really
addressed a true market need despite the solid academic research. As such, regardless of the view of
commercialization risk, the number of investors, the supportiveness of university policies or facilities/staff
to advance the process, the idea itself is not commercialized because it does not contain a value
proposition for any outside entity to take hold of. It is imperative to identify a product-market fit for an
innovation as not all concepts should become companies and not all ideas impact the market. A strong
technology translation capability cannot make up for an opportunity without a direct connection to an
existing customer pain-point, which is only identified through a process of customer discovery outside of
the university’s walls.
Lastly, from a practical perspective, I would recommend that as part of the engagement with a larger set
of academic entrepreneurs on campus (both successful and unsuccessful), the survey/interview deployed
by the authors engage these individuals in soliciting programs, opportunities, efforts, and ideas to improve
the existing stagnant innovation culture on campus. I believe by engaging these “customers” on campus
in dialogue focused on solving the challenge, administrative support will be more easily achieved.
In conclusion, I believe the authors are on the right track and that their efforts have significant merit. I
would urge them to continue their work, expand the sample size, examine a bit broader set of reasons
why the problems exist and work with their respondents to improve the situation.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
Competing Interests: No competing interests were disclosed.
Author Response 04 Aug 2015

Nathan Vanderford, University of Kentucky, USA
Dear Dr. Facher,
Thank you for your time and comments. Your critique has helped guide us through revising the
article. We would like to directly respond to some of your comments. We would first like to clarify
that this case study was designed and conducted as a supplement to the prior study looking at the
barriers associated with cancer research commercialization at the University of Kentucky (we have
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barriers associated with cancer research commercialization at the University of Kentucky (we have
made this clarification in the new version of the article). The prior study’s conclusions were based
solely on the responses to the survey as individual interviews were not conducted. Thus, the intent
of the current study was to collect more specific, supplemental information through interviews with
“successful” entrepreneurs. Given this intent and the study’s supplemental nature, we have
purposefully not incorporated new research questions into the current case study. We have,
however, at your suggestion, expanded the sample size by two respondents and this generated a
number of additional significant comments that are important to understand regarding the
university’s low commercialization rate. We agree with your assertions that additional reasons for
low commercialization activity likely exist and that expanding our research questions and sample
size to include a mix of stakeholders involved in the research commercialization process (including
faculty that have been unsuccessful at commercializing their research and staff/administrators of
the commercialization process, etc.) would aid in uncovering other issues. We would like to note,
however, that expansion of this current work would change the intent (described above) and
design of our study. Therefore, we have maintained the overall intent and design of the study other
than adding the additional respondents. We believe that this design will allow us to bring some
additional closure to the prior study. Lastly, to offset additional concerns, we have included a
description of the limitations of this case study in the methods sections.
In closing, we hope that you will review this revised version of the article in light of our changes
based on your comments as well as those of the other two reviewers (we hope that you will read
the other reviewers’ comments as well as our response to those reviews) and in relation to its
intended purpose of being a supplemental component to the prior study at the University of
Kentucky.
Sincerely,
Nathan L. Vanderford and Elizabeth Marcinkowski
Competing Interests: No competing interests were disclosed.

Referee Report 17 June 2015

doi:10.5256/f1000research.6961.r9005
Scott Crick
Licensing Associate, Office of Technology Management, Washington University, St Louis, MO, USA
This study attempted to identify potential impediments to commercialization of research at the University
of Kentucky. The authors point out that, according to data from AUTM, the University of Kentucky ranks
near the bottom in a number of key metrics of commercialization when compared to its benchmark
institutions. The goal of the study was to identify barriers to commercialization. These findings will then be
brought to administration in hopes of rectifying the problem.
I think there are several issues with this work that, if addressed properly, will greatly strengthen its impact
and utility not only at UK but also at other university technology transfer organizations.
The first issue I have with the work is the inclusion of only a single faculty member with entrepreneurial
experience. The rationale given was that that person could provide more insight into the process as a
whole. Looking at the data referenced in Table 1, the most striking discrepancy between UK and
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whole. Looking at the data referenced in Table 1, the most striking discrepancy between UK and
benchmark institutions is the number of invention disclosures. When the data are normalized to the
number of invention disclosures per institution, UK appears to be making good use of the inventions that
are disclosed to them. It seems to me that one of the major issues at UK is simply getting inventors. While
I agree that the entrepreneurial faculty member could have a lot of insight into issues after the first step, I
wonder how much insight this person provided with regards to why people are not disclosing inventions. I
am certain it would be possible to identify faculty that publicly disclosed potentially valuable assets
without ever filing an invention disclosure, and I would suggest understanding those issues are 1)
extremely important for improving commercialization at UK, and 2) more easily addressable at an
institutional level than some other potential barriers.
The second issue with relying on input from a single faculty member is that barriers are variable (as even
mentioned in the article) not only between individuals, but between disciplines and sub-disciplines as
well. Although the individual faculty member can identify barriers he/she has experienced, it would be
disingenuous to suggest these barriers and the relative weight given to each of them is an accurate
reflection of the system as a whole. A minor point....It would also be very helpful to know general field of
research of the faculty member interviewed. "Translational" is very broad. Is he/she in pharma, biotech,
medical devices, engineering...?
I have two recommendations to strengthen this article.
My first recommendation is that the authors include in the case study at least two other faculty members
with technology commercialization experience (not necessarily on par with the initial interviewee). I would
also suggest that these faculty be from distinct research areas and departments. Although still qualitative,
it would be insightful to see if these people with different types of technology, different department
makeup, and very likely different experiences and backgrounds still identify the same barriers.
My second recommendation is to limit the scope to barriers that are perceived after invention disclosure.
It appears as though there is an issue at UK (which I should say is certainly not unique) that I suspect has
to do with education of potential inventors such that a number of these people are not even considering
that their technology might have commercialization potential. A follow-up study trying to tease apart this
issue would be interesting and may have broader appeal.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
Competing Interests: No competing interests were disclosed.
Author Response 04 Aug 2015

Nathan Vanderford, University of Kentucky, USA
Dear Dr. Crick,
We thank you for taking the time to review our case study. Your critique has helped shape our
current version of the article. We would like to respond to some of your comments. First, per your
suggestion, we have expanded our sample size by two respondents. This expansion lead to the
collection of a significant amount of additional crucial comments that are important to understand
about the issues related to the low commercialization activity at the University of Kentucky.
Second, in regard to your question about the respondents’ field of research, we understand your
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Second, in regard to your question about the respondents’ field of research, we understand your
desire to have more information regarding the respondents’ research areas, but we feel that for
confidentiality purposes, we cannot be any more specific; given the small sample size of
“successful” academic entrepreneurs at the University of Kentucky, reporting a respondent’s
specific research field could potentially allow for the identification of the subject. Next, you made
very insightful comments regarding the desire to better understand the issues involved in the
university’s low invention disclosure rate. We agree with your points and we would also like to
address this issue. With that said, however, we would like to clarify that this case study was
designed and conducted as a supplement to the prior study looking at the barriers associated with
cancer research commercialization at the University of Kentucky; the sole intent of the current
study was to collect more specific, supplemental information through interviews with the
respondents (we have now explicitly stated this intent in the new version of the article). Given this
intent and the study’s supplemental nature, we have purposefully not incorporated new research
questions into the current case study. We feel that expanding the current study would likely change
its primary intent. We do hope to address additional research questions, including understanding
issues related to the low disclosure rate, in future work. Lastly, to offset additional concerns, we
have included a description of the limitations of this case study in the methods sections.
In closing, we hope that you will review this revised version of the article in light of our changes
based on your comments as well as those of the other two reviewers (we hope that you will read
the other reviewers’ comments as well as our response to those reviews) and in relation to its
intended purpose of being a supplemental component to the prior study at the University of
Kentucky.
Sincerely,
Nathan L. Vanderford and Elizabeth Marcinkowski
Competing Interests: No competing interests were disclosed.

Referee Report 05 June 2015

doi:10.5256/f1000research.6961.r8827
Jessica Silvaggi
UWM Research Foundation, Milwaukee, WI, USA
The goal of the authors was to document any impediments to the commercialization process at the
University of Kentucky. The study was spurred by the findings that UK significantly underperforms when
compared to peer institutions of similar size. A previous study was published in 2013 regarding this same
topic at UK for the commercialization of cancer research. In this study, similar surveys were conducted
with one single entrepreneurial respondent as opposed to a larger cohort of cancer researchers in the
previous UK study.
They report that the major issue impeding commercialization, according to the respondent, is the lack of
appropriate infrastructure at the university. The results were apparently similar to those found in this 2013
paper. I found this topic to be of great interest in comparing the performance to schools of similar
benchmarks. The results could be helpful to many institutions that are underperforming and looking to
boost commercialization. The survey questions used could be useful for any institution to keep track of the
satisfaction of the researchers in regard to commercialization of their technologies, and to assess the
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satisfaction of the researchers in regard to commercialization of their technologies, and to assess the
adequacy of the performance of the technology transfer office.
Major concerns/Revisions
1. While I think the survey questions used were reasonable, I have doubts about the validity of asking
a single entrepreneur the survey questions. It comes across as if the same 2013 study was
repeated, but with only one person. I don’t feel that one person is a significant number for this type
of paper to make conclusions with. N=1 doesn’t seem to be a true scientific sampling.
Unfortunately, if more respondents were utilized, then this paper would appear to be a repeat of the
earlier study. Perhaps another angle would be to survey the staff at UK as to why they are
underperforming. Asking the tech transfer professionals and other research administrators would
also be informative and provide a different angle to the original survey of cancer researchers. Or
perhaps a broader survey of other departments would be helpful, rather than only focusing on the
cancer department.
2. I feel that several other angles could have also been explored in this paper to contrast or follow up
on the work in the 2013 paper about UK. After the first study were any changes made based on the
conclusions? Did the number of staff change? Did any of the infrastructure change at UK? Did UK
do anything to increase the level of commercialization? There are many other interesting questions
that could be explored rather than repeating the study over again with one participant.
3. If the university has not responded to the previous study in any fashion, I find that of great interest.
Why hasn’t the technology transfer office been expanded and further supported? Why is there no
incentive by those in charge of this area to revamp the office? There has been a large push at
many universities to further promote entrepreneurship in faculty and students and support
commercialization. In some online information it states that in the past UK was pushing to be a top
20 university by 2020. I am curious to know why there has been no change in the recent years.
Minor Revisions
1. When comparing benchmarks, another important factor missing in the table is the amount of
research dollars. There is a ratio of expected disclosures per millions of dollars of research which
varies, but is quoted in several locations at 1 disclosure per $1.5M-$3M and 1 start-up company
per ~$100M. Knowing the amount of research dollars going into UK would help to show a lack of
productivity with inventions at the university. This information should be available through AUTM if
not through the technology transfer office directly. Based on some online information the research
expenditures at UK appear to be in the hundreds of millions of dollars. Assuming ~$400M in
expenditures, one would expect about 130 disclosures. The UK website cites 84 disclosures in
2014.
Summary:
I feel that major revisions are necessary for this paper to add some new information and expand the
scope of the study. The results here do not seem to add onto those previously found but simply confirm
the previous findings with the survey of one entrepreneurial researcher. A different sample of respondents
would greatly enhance this paper such as asking researchers from all departments, or focusing on the
staff involved in technology transfer, commercialization and entrepreneurship. Or perhaps if changes
were made by the tech transfer office and these did not have an effect, this would be good to know for
other offices. There appears to be something missing from this story. This paper would be of interest if
revamped to add a new twist distinct from the 2013 paper.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an
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I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an
acceptable scientific standard.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
Competing Interests: No competing interests were disclosed.
Author Response 04 Aug 2015

Nathan Vanderford, University of Kentucky, USA
Dear Dr. Silvaggi,
We greatly appreciate the time you dedicated to review our article. We found your comments very
helpful as we revised the article. We are happy that you found this topic of interest and applicable
to other institutions. Before reading the new version, we would like to address some of your
comments and concerns. First, we appreciate your concerns regarding the “n-of-1” design of the
study. As suggested by each reviewer, we have added two additional respondents to the study and
this did indeed generate several additional important points regarding the issues related to the low
commercialization activity at the University of Kentucky. Second, we appreciate your comments
regarding how this work could be construed as a repeat of the prior study. We agree with your
assertions that other issues are likely involved in the low commercialization activity at the university
and we agree that surveying a mix of stakeholders involved in the research commercialization
process could aid in uncovering other issues. However, we would like to clarify that this case study
was, in fact, specifically designed and conducted as a supplement to the prior work looking at the
barriers associated with cancer research commercialization at the University of Kentucky (we have
made this clarification in the new version of the article). The prior study’s conclusions were based
solely on the responses to the survey and individual interviews were not conducted. The intent of
the current study was to collect more specific, supplemental information through interviews. Given
this intent and the study’s supplemental nature, we have purposefully not incorporated new
research questions into the current case study. We believe that future work would best address
many of your comments which add additional research questions that would help understand other
issues that may be connected to the low research commercialization activity. You have also made
several important comments regarding whether the university has made any changes in the
research commercialization process since the 2013 study. In fact, few changes have been made
and that is one reason why it was important to conduct this case study; it was important to obtain
specific comments from “successful” entrepreneurs so that these individuals could identify specific
issues in the system. Finally, to offset additional concerns, we have included a description of the
limitations of this case study in the methods sections. Per your minor point, we have now also
added research expenditures to Table 1.
In closing, we hope that you will review this revised version of the article in light of our changes
based on your comments as well as those of the other two reviewers (we hope that you will read
the other reviewers’ comments as well as our response to those reviews) and in relation to its
intended purpose of being a supplemental component to the prior study at the University of
Kentucky.
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Sincerely,
Nathan L. Vanderford and Elizabeth Marcinkowski
Competing Interests: No competing interests were disclosed.
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